Distribution of pathogenic bacteria and immune status in patients with pulmonary infection after lung cancer treatment / 公共卫生与预防医学

ABSTRACT

Objective To explore distribution of pathogenic bacteria and immune status in patients with pulmonary infection after lung cancer treatment. Methods A total of 102 patients with pulmonary infection after lung cancer treatment (infection group) who were admitted to our hospital from September 2015 to October 2019 were selected, and 120 patients without pulmonary infection after lung cancer treatment were enrolled in the same period (control group). The species, distribution, drug resistance rate of pathogenic bacteria of the infected group were analyzed. The immune status, serum neuron-specific enolase (NSE), squamous cell carcinoma associated antigen (SCC) and carcinoembryonic antigen (CEA) levels of the two groups were compared. Results A total of 174 strains of pathogenic bacteria were isolated and cultured from 102 patients in the infected group, of which 94 strains were gram-negative (accounting for 54.02%), mainly Klebsiella pneumoniae and Pseudomonas aeruginosa, and 46 strains were gram-positive bacteria (26.44%), mainly Staphylococcus aureus and Coagulase-negative staphylococcus. In addition, there were 34 strains of fungus (19.54%). Gram-negative bacteria were resistant to aztreonam and cefotaxime, while gram-positive bacteria were resistant to penicillin and erythromycin. The serum levels of NSE, SCC and CEA in the infected group were higher than those in the control group (P<0.05). The levels of CD3+, CD4+ and CD4+/CD8+ in peripheral blood of the infected group were lower than those in the control group (P<0.05). Conclusion After lung cancer treatment, the pathogenic bacteria of patients with pulmonary infection were mainly gram-negative bacteria. The immune function of patients with pulmonary infection decreased, and the tumor markers such as serum NSE and SCC increased.